Sleep disorders and sleep medications as risk factors for dementia in kidney transplant recipients: A retrospective cohort study
Open Access
- 18 June 2025
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (11) , 2387-2397
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Aging (K01DK139420)
- National Institute on Aging (F32AG082486)
- National Institute on Aging (K01DK132490)
- National Institute of Allergy and Infectious Diseases (K24AI144954)
This publication has 62 references indexed in Scilit:
- Benzodiazepine Discontinuation and Mortality Among Patients Receiving Long-Term Benzodiazepine TherapyJAMA Network Open, 2023
- Sleep Disturbances and Dementia Risk in Older Adults: Findings From 10 Years of National U.S. Prospective DataAmerican Journal of Preventive Medicine, 2023
- Disparities in Sleep Health and Potential Intervention ModelsChest, 2021
- A Systematic Review of the Neurocognitive Effects of Cannabis Use in Older AdultsCurrent Addiction Reports, 2019
- Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative reviewJournal of General Internal Medicine, 2018
- Underdiagnosis of Dementia: an Observational Study of Patterns in Diagnosis and Awareness in US Older AdultsJournal of General Internal Medicine, 2018
- Practical recommendations for reportingFine‐Gray model analyses for competing risk dataStatistics in Medicine, 2017
- Public health burden of sleep disorders: underreported problemJournal of Public Health, 2016
- Cumulative Use of Strong Anticholinergics and Incident DementiaJAMA Internal Medicine, 2015
- Sleep disorders and quality of life in renal transplant recipientsInternational Urology and Nephrology, 2009